干细胞之家 - 中国干细胞行业门户第一站

 

 

搜索
中源协和

免疫细胞治疗专区

欢迎关注干细胞微信公众号

  
查看: 23092|回复: 0
go

Bioluminescent ...Thyroid Cancer Growth and Metastases In Vivo. [复制链接]

Rank: 3Rank: 3

积分
304 
威望
304  
包包
1567  

优秀会员

楼主
发表于 2014-6-4 11:31 |只看该作者 |倒序浏览 |打印
干细胞之家微信公众号
Bioluminescent Human Thyrospheres Allow Noninvasive Detection of Anaplastic Thyroid Cancer Growth and Metastases In Vivo.
- k, L( W9 }: Y4 h" J" ]  d7 o# }Ashley Reeb, Wen Li, Reigh-Yi Lin
$ [; g7 n+ T) `8 k' Q) dThyroid: official journal of the American Thyroid Association (Impact Factor: 2.6). 03/2014; DOI:10.1089/thy.2014.0014
( b; t6 {3 P2 e( zSource: PubMed
# W) d5 }! H; j0 g* m; w; lABSTRACT Background: We have previously demonstrated that thyrospheres derived from human anaplastic thyroid cancer (ATC) cell lines can reconstitute and sustain tumor growth in vivo. The aim of this study was to use luciferase-expressing thyrospheres to establish a clinically relevant mouse model of ATC that allows noninvasive and sensitive monitoring of tumor progression. Methods: Two human ATC cell lines stably transfected with a firefly luciferase gene were used to generate thyrospheres under stem cell culture conditions. Cells were orthotopically implanted into the thyroids of immunodeficient NOD/SCIDIl2rg-/- mice to initiate tumors. Tumor progression and metastasis were evaluated by bioluminescent imaging weekly as well as histological analysis postmortem. Results: We show that only 100 thyrosphere cells are needed for tumor development, and that tumors can be monitored with bioluminescent imaging as early as 7-14 days after implantation. Subsequent histological evaluation of tissue sections confirmed characteristics of high-grade malignant neoplasms. Conclusions: This approach offers rapid and highly sensitive noninvasive detection options for the preclinical assessment of novel ATC therapeutics in vivo.
% e, ?5 v: ]# F; C- Zwww.researchgate.net/publication ... _Metastases_In_Vivo
‹ 上一主题|下一主题
你需要登录后才可以回帖 登录 | 注册
验证问答 换一个

Archiver|干细胞之家 ( 吉ICP备2021004615号-3 )

GMT+8, 2026-6-30 10:45

Powered by Discuz! X1.5

© 2001-2010 Comsenz Inc.